Analyst calls: RTP, INTC, VIA.B, TEF, BRCD, JBL, ERIC, CEPH ...


Analyst upgrades:
  • Citigroup upgraded shares of Ball (NYSE: BLL) to Buy from Hold and raised its target to $45 from $41 as they believe recent capacity closures will be positive for beverage can operating rates.
  • Deutsche Bank upgraded Rio Tinto (NYSE: RTP) to Buy from Hold on valuation and the company's plans to preserve cash.
  • ThinkPanmure upgraded Intel (NASDAQ: INTC) to Accumulate from Sell and raised its target to $17 from $12 citing trough earnings in 2009 and lowered expectations.
  • Viacom B (NYSE: VIA.B) was added to Goldman's Conviction Buy List.
  • Telefonica (NYSE: TEF) was upgraded to Outperform from Neutral at Credit Suisse.
  • Onyx Pharma (NASDAQ: ONXX) was raised to Overweight from Neutral at JP Morgan.
Analyst downgrades:
  • Jefferies downgraded shares of Foundry Networks (NASDAQ: FDRY) to Hold from Buy and lowered its target to $16.50 from $19.25 as they expect the Brocade (NASDAQ: BRCD) acquisition to close by year-end.
  • Merrill downgraded Ericsson (NASDAQ: ERIC) to Underperform from Buy based on valuation and a potential pre-announcement from the Sony Ericsson JV.
  • KeyBanc downgraded Pacer International (NASDAQ: PACR) to Underperform from Neutral based on softer-industry volumes and lower fuel prices that lag their fuel surcharge paid to underlying rail carriers.
  • eTelecare Global (NASDAQ: ETEL) was cut to Neutral from Outperform at Baird.
  • Fiat (OTC: FIATY) was lowered to Underweight from Overweight at Morgan Stanley.
  • Jabil Circuit (NYSE: JBL) was downgraded at Citigroup to Sell from Hold.
Analyst initiations:
  • Jefferies initiated Brocade (NASDAQ: BRCD) with a Hold rating and $3.50 target. The firm wants additional clarity on guidance post the Foundry (NASDAQ: FDRY) acquisition before becoming more positive on the stock.
  • Morgan Keegan is positive on National Healthcare's (NYSE: NHC) balance sheet and focus on offering high-acuity short-stay services at their nursing homes. Shares were assumed with an Outperform rating.
  • Cephalon (NASDAQ: CEPH) was initiated at Soleil with a Buy rating and $92 target. Soleil is positive on the company's diversified revenue base and growth drivers.
  • Washington Reit (NYSE: WRE) was started with a Neutral at JP Morgan.
  • Key Energy (NYSE: KEG) was initiated with a Neutral rating and $5.50 at UBS.
  • Alexion Pharma (NASDAQ: ALXN) was initiated with an Overweight rating and $44 target at Thomas Weisel.
Symbol Lookup
IndexesChangePrice
DJIA+6.5112,890.46
NASDAQ+11.372,927.23
S&P 500+1.991,351.95

Last updated: February 09, 2012: 11:19 PM

Hot Stocks

General Electric

19.13-0.11(-0.57)

Alcoa

10.64-0.03(-0.28)

Apple Inc

493.17+16.49(+3.46)

Google Inc 'A'

611.46+1.61(+0.26)

Bank of America

8.18+0.05(+0.62)

Wal-Mart Stores

61.96+0.34(+0.55)

Exxon Mobil Corp

84.88-0.44(-0.52)

Ford

12.69-0.15(-1.17)

Citigroup

33.66-0.57(-1.67)

IBM

193.13+0.18(+0.09)

Yahoo

16.00+0.22(+1.39)

Starbucks

49.20+0.48(+0.99)

Microsoft

30.77+0.11(+0.36)

Home Depot

45.27+0.10(+0.22)

DailyFinance Headlines

Benzinga Headlines

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

DailyFinance BlackBerry App

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

BioHealth Investor Headlines

Page Loaded in 1328847563495 ms.